参考文献/References:
[1] KAYSER S,LEVIS M J.The clinical impact of the molecular landscape of acute myeloid leukemia[J].〖KG-\*4〗Haematologica,2023,108(2):308-320.
[2] NABIL R,HASSAN N M,ABDELLATEIF M S,et al.The prognostic role of C-KIT,TET1 and TET2 gene expression in acute myeloid leukemia[J].Mol Biol Rep,2023,50(1):641-653.
[3] DHNER H,WEI A H,APPELBAUM F R,et al.Diagnosis and management of AML in adults:2022 recommendations from an international expert panel on behalf of the ELN[J].Blood,2022,140(12):1345-1377.
[4] SIMONS A,SHAFFER L G,HASTINGS R J.Cytogenetic nomenclature:changes in the ISCN 2013 compared to the 2009 edition[J].Cytogenet Genome Res,2013,141(1):1-6.
[5] 中华医学会血液学分会白血病淋巴瘤学组.成人急性髓系白血病(非急性早幼粒细胞白血病)中国诊疗指南(2023年版)[J].中华血液学杂志,2023,44(9):705-712.
LEUKEMIA & LYMPHOMA GROUP,CHINESE SOCIETY OF HEMATOLOGY,CHINESE MEDICAL ASSOCIATION.Chinese guidelines for diagnosis and treatment of adult acute myeloid leukemia (not APL) (2023)[J].Chin J Hematol,2023,44(9):705-712.
[6] FAN H,LI Y,LIU C,et al.Circular RNA-100290 promotes cell proliferation and inhibits apoptosis in acute myeloid leukemia cells via sponging miR-203[J].Biochem Biophys Res Commun,2018,507(1/2/3/4):178-184.
[7] 徐涛,颜慕霞,徐令,等.环状RNA circOMA1对儿童急性髓系白血病细胞增殖和凋亡的影响[J].中华实用儿科临床杂志,2022,37(11):831-836.
XU T,YAN M X,XU L,et al.Effects of circular RNA circOMA1 on cell proliferation and apoptosis of children with acute myeloid leukemia[J].Chin J Appl Clin Pediatr,2022,37(11):831-836.
[8] 张晓冬,林晓媛.急性髓系白血病患者外周血调节性T细胞、辅助性T细胞17及其相关细胞因子的表达及意义[J].新乡医学院学报,2023,40(4):339-342,352.
ZHANG X D,LIN X Y.Expression and significance of regulatory T cells,helper T cell 17 cells and their related cytokines in peripheral blood of patients with acute myeloid leukemia[J].J Xinxiang Med Univ,2023,40(4):339-342,352.
〖HJ1.8mm〗[9] STUBBINS R J,FRANCIS A,KUCHENBAUER F,et al.Management of acute myeloid leukemia:a review for general practitioners in oncology[J].Curr Oncol,2022,29(9):6245-6259.
[10] OCHS M A,MARINI B L,PERISSINOTTI A J,et al.Oncology stewardship in acute myeloid leukemia[J].Ann Hematol,2022,101(8):1627-1644.
[11] THIEBLEMONT C,PHILLIPS T,GHESQUIERES H,et al.Epcoritamab,a novel,subcutaneous CD3xCD20 bispecific T-cell-engaging antibody,in relapsed or refractory large B-cell lymphoma:dose expansion in a phase I/II trial[J].J Clin Oncol,2023,41(12):2238-2247.
[12] ZHANG J,HU Y,YANG J,et al.Non-viral,specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL[J].Nature,2022,609(7926):369-374.
[13] SHIMONY S,STAHL M,STONE R M.Acute myeloid leukemia:2023 update on diagnosis,risk-stratification,and management[J].Am J Hematol,2023,98(3):502-526.
[14] KATAGIRI S,CHI S,MINAMI Y,et al.Mutated KIT tyrosine kinase as a novel molecular target in acute myeloid leukemia[J].Int J Mol Sci,2022,23(9):4694.
[15] MATSUNAGA T,TAKEMOTO N,SATO T,et al.Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia[J].Nat Med,2003,9(9):1158-1165.
[16] DINARDO C D,ERBA H P,FREEMAN S D,et al.Acute myeloid leukaemia[J].Lancet,2023,401(10393):2073-2086.
[17] AKRAM A M,HASSAN M,CHAUDHARY A,et al.Identification and in silico analysis of noval alteration Arg420Gly in KIT proto oncogene among acute myeloid leukemia patients[J].Sci Rep,2022,12(1):19252.
[18] SPAARGAREN M.Ibrutinib for AML? Check CD117 (KIT)![J].Lancet Haematol,2015,2(5):e180-e181.
[19] OELLERICH T,MOHR S,CORSO J,et al.FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation[J].Blood,2015,125(12):1936-1947.
[20] RUSHWORTH S A,PILLINGER G,ABDUL-AZIZ A,et al.Activity of Bruton′s tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia:a mechanistic study using patient-derived blast cells[J].Lancet Haematol,2015,2(5):e204-e211.
[21] HEO S K,NOH E K,KIM J Y,et al.Radotinib induces high cytotoxicity in c-KIT positive acute myeloid leukemia cells[J].Eur J Pharmacol,2017,804:52-56.
[22] HEO S K,NOH E K,KIM J Y,et al.Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death[J].Sci Rep,2017,7(1):15278.
[23] 陶善东,邓媛,何正梅,等.Btk及NFκB在急性髓系白血病细胞中的表达及其意义[J].中国实验血液学杂志,2013,21(1):25-28.
TAO S D,DENG Y,HE Z M,et al.Expression of Btk and NFκB in acute myeloid leukemia cells and its significance[J].J Exp Hematol,2013,21(1):25-28.
相似文献/References:
[1]张婧婧,张楠,王侠,等.急性髓系白血病四色流式细胞术免疫学分型特点分析[J].新乡医学院学报,2011,28(03):323.
[2]崔珊珊,李雅慧,赵晨瑾,等.二甲双胍对人急性髓系白血病KG1a细胞增殖和凋亡的影响及其机制[J].新乡医学院学报,2021,38(10):901.[doi:10.7683/xxyxyxb.2021.10.001]
CUI Shanshan,LI Yahui,ZHAO Chenjin,et al.Effect and mechanism of metformin on proliferation and apoptosis of human acute myeloid leukemia KG1a cells[J].Journal of Xinxiang Medical University,2021,38(4):901.[doi:10.7683/xxyxyxb.2021.10.001]
[3]赵小强,吴雅莉,仝佳音,等.鱼藤素对急性髓系白血病KG-1a细胞增殖和凋亡的影响及机制[J].新乡医学院学报,2021,38(12):1121.[doi:10.7683/xxyxyxb.2021.12.003]
ZHAO Xiaoqiang,WU Yali,TONG Jiayin,et al.Effect of deguelin on the proliferation and apoptosis of acute myeloid leukemia KG-1a cells and its mechanism[J].Journal of Xinxiang Medical University,2021,38(4):1121.[doi:10.7683/xxyxyxb.2021.12.003]
[4]张军伟.成人与儿童急性淋巴细胞白血病免疫表型、染色体和分子遗传学异常分析[J].新乡医学院学报,2022,39(1):060.[doi:10.7683/xxyxyxb.2022.01.013]
ZHANG Junwei.Analysis of immunophenotype,chromosomal and molecular genetic abnormalities in adults and children with acute lymphoblastic leukemia[J].Journal of Xinxiang Medical University,2022,39(4):060.[doi:10.7683/xxyxyxb.2022.01.013]
[5]张彦平,刘蒙蒙,展新荣.地西他滨联合小剂量高三尖杉酯碱和阿糖胞苷治疗老年急性髓系白血病疗效观察[J].新乡医学院学报,2020,37(11):1068.[doi:10.7683/xxyxyxb.2020.11.014]
ZHANG Yanping,LIU Mengmeng,ZHAN Xinrong.Effect of decitabine combined with low-dose homoharringtonine and cytarabine in the treatment of elderly patients with acute myeloid leukemia[J].Journal of Xinxiang Medical University,2020,37(4):1068.[doi:10.7683/xxyxyxb.2020.11.014]
[6]申清云,高 大.老年急性髓系白血病的治疗方法研究进展[J].新乡医学院学报,2019,36(1):096.[doi:10.7683/xxyxyxb.2019.01.022]
[7]张彦平,刘蒙蒙,展新荣.地西他滨联合三氧化二砷治疗老年急性髓系白血病的疗效及安全性[J].新乡医学院学报,2019,36(12):1163.[doi:10.7683/xxyxyxb.2019.12.015]
ZHANG Yan-ping,LIU Meng-meng,ZHAN Xin-rong.Evaluation of the efficacy and safety of decitabine combined with arsenic trioxide in the treatment of senile acute myeloid leukemia[J].Journal of Xinxiang Medical University,2019,36(4):1163.[doi:10.7683/xxyxyxb.2019.12.015]
[8]王继芳,魏秀丽.氟达拉滨联合阿糖胞苷治疗急性髓系白血病疗效观察[J].新乡医学院学报,2018,35(3):204.[doi:10.7683/xxyxyxb.2018.03.011]
WANG Ji-fang,WEI Xiu-li.Effect of fludarabine combined with cytarabine on acute myeloid leukemia[J].Journal of Xinxiang Medical University,2018,35(4):204.[doi:10.7683/xxyxyxb.2018.03.011]
[9]尹俊杰,梁 波,王继芳,等.阿柔比星为基础的联合化学治疗方案治疗成人初治急性髓系白血病疗效观察[J].新乡医学院学报,2017,34(1):072.[doi:10.7683/xxyxyxb.2017.01.021]
YIN Jun-jie,LIANG Bo,WANG Ji-fang,et al.Efficacy of aclarubicin-based chemotherapy induction regimens for adult de-novo acute myeloid leukemia[J].Journal of Xinxiang Medical University,2017,34(4):072.[doi:10.7683/xxyxyxb.2017.01.021]
[10]孟君霞,武永强,唐 广,等.CD7抗原表达与急性髓系白血病临床特征、细胞遗传学特点及预后的关系[J].新乡医学院学报,2016,33(6):508.[doi:10.7683/xxyxyxb.2016.06.017]
MENG Jun-xia,WU Yong-qiang,TANG Guang,et al.Relationship between CD7 antigen expression and clinical features,cytogenetic features,prognosis of acute myeloid leukemia[J].Journal of Xinxiang Medical University,2016,33(4):508.[doi:10.7683/xxyxyxb.2016.06.017]